Long-term Use of 5α-Reductase Inhibitors and the Risk of Male Breast Cancer.

R.G. Duijnhoven, S.M.J.M. Straus, P.C. Souverein, A. de Boer, J.L.H.R. Bosch, A.W. Hoes, M.L. De Bruin

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Long-term Use of 5α-Reductase Inhibitors and the Risk of Male Breast Cancer.'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology